OnCore, TKMR complete reverse merger, creating HBV-focused company: http://finance.yahoo.com/news/tekmira-announces-completion-merger-oncore-004000982.html The total shares outstanding on closing of the transaction are 46,517,496 with fully diluted shares of 49,657,061.